Tag: Chemistry42

AI-driven platform discovers PHD inhibitor for anemia treatment

In Silico Medicine’s Chemistry42 platform has led to the discovery of a novel PHD inhibitor for the treatment of anemia. The inhibitor has shown promising results in treating anemia induced by chronic kidney disease (CKD), with potential global implications. Utilizing structure-based drug discovery and AI-generated candidates, the lead compound 15 demonstrated favorable in vitro/in vivo […]

DAILY LINKS TO YOUR INBOX

PROMPT ENGINEERING

Prompt Engineering Guides

ShareGPT

 

©2024 The Horizon